Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
New medicines: human
Get the latest updates from New medicines: human directly as they happen.
Follow now 398 followers
Latest posts
Last updated 18 days ago
Human medicines European public assessment report (EPAR): Fluad, influenza vaccine (surface antigen, inactivated, adjuvanted), Status: Opinion
18 days ago
Human medicines European public assessment report (EPAR): Fluad, influenza vaccine (surface antigen...
Human medicines European public assessment report (EPAR): Buprenorphine Neuraxpharm, buprenorphine, Status: Opinion
18 days ago
Human medicines European public assessment report (EPAR): Buprenorphine Neuraxpharm, buprenorphine, Status: Opinion
Human medicines European public assessment report (EPAR): Absimky, ustekinumab, Status: Opinion
18 days ago
Human medicines European public assessment report (EPAR): Absimky, ustekinumab, Status: Opinion
Human medicines European public assessment report (EPAR): Siiltibcy, rdESAT-6 / rCFP-10, Status: Opinion
18 days ago
Human medicines European public assessment report (EPAR): Siiltibcy, rdESAT-6 / rCFP-10, Status...
Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Status: Opinion
18 days ago
Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Status: Opinion
Human medicines European public assessment report (EPAR): Eltrombopag Viatris, eltrombopag, Status: Opinion
18 days ago
Human medicines European public assessment report (EPAR): Eltrombopag Viatris, eltrombopag, Status: Opinion
Human medicines European public assessment report (EPAR): Imuldosa, ustekinumab, Status: Opinion
18 days ago
Human medicines European public assessment report (EPAR): Imuldosa, ustekinumab, Status: Opinion
Human medicines European public assessment report (EPAR): Alhemo, concizumab, Status: Opinion
18 days ago
Human medicines European public assessment report (EPAR): Alhemo, concizumab, Status: Opinion
Human medicines European public assessment report (EPAR): Flucelvax, influenza vaccine (surface antigen, inactivated, prepared in cell cultures), Status: Opinion
18 days ago
Human medicines European public assessment report (EPAR): Flucelvax, influenza vaccine (surface antigen...
Human medicines European public assessment report (EPAR): Wainzua, eplontersen, Status: Opinion
18 days ago
Human medicines European public assessment report (EPAR): Wainzua, eplontersen, Status: Opinion
Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Status: Opinion
about 2 months ago
Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Status: Opinion
Human medicines European public assessment report (EPAR): Pomalidomide Teva, pomalidomide, Status: Opinion
about 2 months ago
Human medicines European public assessment report (EPAR): Pomalidomide Teva, pomalidomide, Status: Opinion